about
Severe acute respiratory syndrome coronavirus 3a protein is a viral structural proteinOutbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviationsJunín virus pathogenesis and virus replicationTransmission of Ebola viruses: what we know and what we do not knowSyndromic surveillance and bioterrorism-related epidemicsRole of the endothelium in viral hemorrhagic fevers.Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs.Severe Rift Valley fever may present with a characteristic clinical syndromeEndothelial cell permeability and adherens junction disruption induced by junín virus infectionRIG-I enhanced interferon independent apoptosis upon Junin virus infection.Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cellsPostepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort studyPhylogenetic relationships among members of the genus Phlebovirus (Bunyaviridae) based on partial M segment sequence analyses.Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus.Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.Interepidemic Rift Valley fever virus seropositivity, northeastern KenyaBilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells.Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cellsPotential for autoimmune pathogenesis of Rift Valley Fever virus retinitisDifferential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirusDiseases of the central nervous system caused by lymphocytic choriomeningitis virus and other arenaviruses.Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials.Cis-acting elements in the antigenomic promoter of Nipah virus.Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats.Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor.Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection.Natural nidality in Bolivian hemorrhagic fever and the systematics of the reservoir species.Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not KnowFilovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.Past, present, and future of arenavirus taxonomy.Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus.Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018.
P50
Q24556675-3BE036BE-BF74-4B06-81B6-B26969DC12EAQ24603794-82118EE1-6574-4E8D-8F9D-E91F7473FECBQ24620453-106A2024-667A-4DDC-9184-AE8812DE2AA9Q26992011-15202591-D5A6-46BF-B8B0-13714E241EA9Q28083565-F8900700-DE69-4F89-AD11-5BE19906D9E6Q28386064-B388450B-8034-4782-A475-DF8BDE04F578Q33342361-3653C7C2-407A-4EA1-9179-E7962B3AB983Q33380669-B52F4659-AB13-455C-9790-8B13E65B3FABQ33693574-7A6C3EF2-4B7C-425D-B353-74EE7A645BEDQ33719699-023A95C8-2BF3-4253-915F-D7AEBB211E9BQ33740309-EAE6CC02-77E6-45A1-A780-D71ED908D6A4Q33908658-FE05D8CC-88A2-4B82-804D-4F2910FD0F9DQ34000103-C6B68E4B-E774-4D97-A8DF-0F7AADB14B16Q34174193-57E78D0A-254D-494C-AC0B-1F34804BC04DQ34247261-DC8B7771-E6CA-45C4-9BC5-7517F76BD05DQ34399575-F619A623-EF92-487E-82CD-0A233F297019Q35635252-6E9EBF1D-BF51-4C51-A13F-514281062319Q36514844-12605961-1452-4BC3-B4B8-FEA2BDD6315AQ37009607-442DF743-D24B-4F38-8AC5-52A4C059D688Q37123548-89E58565-6640-4375-8F71-5FA6566B61F8Q37127923-6DB7FD6E-D8DD-4209-9A70-6A6F6960AFE6Q37166123-64FA19B6-9C33-4CF6-BFED-8BAD8E2360FFQ37191869-AB6834EC-DA51-4AD9-9E75-E0327B06E883Q37320063-12EDCD9B-8079-46CB-8086-EE91AA0CB84AQ37372586-6E1C2F7D-2C9A-4E4B-A65F-AD84555D4C6FQ38228568-AB9AEAFD-C80A-432D-BE8A-82DBB5DFFD70Q39038799-26E02841-B759-4BBD-9180-C84E20DBD08AQ39198268-D393F071-23B5-474F-9884-46F0618D9908Q39365226-3D25005C-126C-4DD4-840E-84754ABEBFD9Q40094212-FDB0EF63-2024-47A9-8EDF-FAF0700E6C14Q40124756-3959A7EE-4C6A-4DB6-8ADE-9249B27C1EC8Q40132046-51C66944-F6AC-464B-B4E1-61ACB6C8C8E5Q40248866-D805100F-F6F1-451C-BD38-601368DF4F6AQ40412073-5D484823-571A-4832-8786-2E62AF4B5AC6Q40557210-90AD70AB-E8FA-48B8-BFCA-027780AA5BB8Q42382051-D9837D83-4A01-4DF4-9B50-2A8D100E56CDQ42934343-4A5884DD-B2FE-4C68-97F4-4B2BE668F3E9Q46734627-3992A007-3754-44DF-9AC4-154B39A590B2Q46903980-3E3122F1-074C-4745-9F7A-02B98C9FB599Q52572051-C7050568-3FA9-47AB-B8A9-EB3BA2686E0C
P50
name
Clarence J Peters
@en
type
label
Clarence J Peters
@en
prefLabel
Clarence J Peters
@en